Evidence map›Paper›PMID 30526612›Full record

ArticleLipids in health and disease2018

Coenzyme Q10 protects against hyperlipidemia-induced cardiac damage in apolipoprotein E-deficient mice.

Xiaoqing Zhang, Hongyang Liu, Yuhua Hao, Lulu Xu, Tiemei Zhang, Yingshu Liu, Lipeng Guo, Liyue Zhu, Zuowei Pei

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Effects of coenzyme Q10 in a propofol infusion syndrome model of rabbits.Asian biomedicine : research, reviews and news · 2023
    Article
  7. Article
  8. Article
  9. Tackling Atherosclerosis via Selected Nutrition.International journal of molecular sciences · 2022
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Atherosclerosis and Coenzyme QInternational journal of molecular sciences · 2019
    Review
  18. The Paradox of Coenzyme QNutrients · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Xiaoqing ZhangDepartment of Infection, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Dalian, China.
Hongyang LiuDepartment of Heart Intensive Care Unit, the First Affiliated Hospital of Dalian Medical University, No.193 Lianhe Road, Dalian, China.
Yuhua HaoDepartment of Infection, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Dalian, China.
Lulu XuDepartment of Infection, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Dalian, China.
Tiemei ZhangDepartment of Infection, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Dalian, China.
Yingshu LiuDepartment of Endocrinology, Dalian Municipal Central Hospital, 42 Xuegong Road, Dalian, China.
Lipeng GuoDepartment of Cardiology, Dalian Third People' Hospital Affiliated to Dalian Medical University, No.40 Qianshan Road, Dalian, China.
Liyue ZhuRehabilitation Center, Zhejiang Hospital, 12 Lingyin Road, Hangzhou, Zhejiang, China.
Zuowei PeiDepartment of Cardiology, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Dalian, China. pzw_dl@163.com.ORCID http://orcid.org/0000-0002-1009-0025
Affiliated Zhongshan Hospital of Dalian University · CNDalian Medical University · CNDalian Municipal Central Hospital · CNZhejiang Hospital · CN

Funding

The social development project of public welfare technology 2015C33121
6 · The paper itself

Abstract

backgroundHyperlipidemia is a well-established risk factor for cardiac damage, which can lead to cardiovascular diseases. Many studies have shown that Coenzyme Q10(CoQ10) protects against cardiac damage in vivo. The aim of this study was to investigate the possible protective effects of CoQ10 against cardiac damage in apolipoprotein E-deficient (ApoE

methodsEight-week-old male C57BL/6 and ApoE

resultsThe metabolic parameters such as total cholesterol (TC), low-density lipoprotein-cholesterol (LDL-c), and triglycerides (TG) levels were lower in ApoE

conclusionsThese results indicate that CoQ10 is a potential therapeutic target for cardiac damage caused by hyperlipidemia.

Indexed as

AnimalsAortaApolipoproteins EAtherosclerosisCardiovascular DiseasesDiet, High-FatDisease Models, AnimalGene Expression RegulationHeart InjuriesHyperlipidemiasInterleukin-6MiceProtective AgentsRisk FactorsTriglyceridesTumor Necrosis Factor-alphaApolipoproteins Ecoenzyme Q10Interleukin-6Protective AgentsTriglyceridesTumor Necrosis Factor-alphaUbiquinone

Identifiers

PMID30526612
PMCPMC6286539
OpenAlexW2903909749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.